Literature DB >> 11901019

Using Bayesian tissue classification to improve the accuracy of vestibular schwannoma volume and growth measurement.

Elizabeth A Vokurka1, Amit Herwadkar, Neil A Thacker, Richard T Ramsden, Alan Jackson.   

Abstract

BACKGROUND AND
PURPOSE: True 3D measurements of tumor volume are time-consuming and subject to errors that are particularly pronounced in cases of small tumors. These problems complicate the routine clinical assessment of tumor growth rates. We examined the accuracy of currently available methods of size and growth measurement of vestibular schwannomas compared with that of a novel fast partial volume tissue classification algorithm.
METHODS: Sixty-three patients with unilateral sporadic vestibular schwannomas underwent imaging. Thirty-eight of these patients underwent imaging two or more times at approximately 12-month intervals. Contrast-enhanced 3D T1-weighted images were used for all measurements. An experienced radiologist performed standard size estimations, including maximal diameter, elliptical area, perimeter, manually segmented area, intensity thresholded seeding volume, and manually segmented volume. A method for calculating volume was also used, incorporating Bayesian probability statistics to estimate partial volume effects. Manually segmented volume was obtained as a baseline standard measure. A computer-generated phantom exhibiting the intensity and partial volume characteristics of brain tissue, CSF, and intracanalicular vestibular schwannoma tissue was used to measure absolute accuracy of the standard technique and Bayesian partial volume segmentation.
RESULTS: The Bayesian partial volume segmentation method showed the highest correlation (R(2) = 0.994) with the standard method, whereas the commonly used method of maximal diameter measurement showed poor correlation (R(2) = 0.732). Accuracy of Bayesian segmentation was shown to be more than twice that of manual segmentation, with an absolute accuracy of 5% (cf, 13%) and a remeasurement accuracy of 70 mm(3) (cf, 150 mm(3)). For the 38 patients who underwent imaging twice, definite tumor growth was shown for 12, potential growth for seven, no growth for 17, and definite shrinkage for two.
CONCLUSION: Commonly used methods such as maximal diameter measurements do not provide adequate statistical accuracy with which to monitor tumor growth in patients with small vestibular schwannomas. Bayesian partial volume segmentation provides a more accurate and rapid method of volume and growth estimation. These differences in measurement accuracy translated into a significant improvement in clinical assessment, allowing identification of tumor growth in 10 of 12 cases that appeared to be static in size when manual segmentation techniques are used. The technique is quick to perform and suitable for use in routine clinical practice.

Entities:  

Mesh:

Year:  2002        PMID: 11901019      PMCID: PMC7975317     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  26 in total

1.  Thallium chloride 201Tl combined with single photon emission computed tomography (SPECT) in the evaluation of vestibular schwannoma growth.

Authors:  S Charabi; N A Lassen; J Thomsen; M Tos; K Rossen; G K Jacobsen
Journal:  Acta Otolaryngol       Date:  1997-01       Impact factor: 1.494

2.  Preoperative and postoperative growth rates in acoustic neuromas documented with CT scanning.

Authors:  J Wazen; H Silverstein; H Norrell; B Besse
Journal:  Otolaryngol Head Neck Surg       Date:  1985-04       Impact factor: 3.497

3.  Radiologic assessment of acoustic neuroma in the elderly. Is no treatment good treatment?

Authors:  E E Kassel; J M Nedzelski; R J Canter; D W Rowed; P W Cooper
Journal:  Acta Radiol Suppl       Date:  1986

4.  Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease.

Authors:  N C Fox; P A Freeborough
Journal:  J Magn Reson Imaging       Date:  1997 Nov-Dec       Impact factor: 4.813

5.  The growth of acoustic neuromas in volumetric radiologic assessment.

Authors:  K Niemczyk; F M Vaneecloo; L Lemaitre; J P Lejeune; H Skarzynski; F Dubrulle; C Vincent
Journal:  Am J Otol       Date:  1999-03

6.  Growth potential of acoustic neuromas.

Authors:  J Wennerberg; U Mercke
Journal:  Am J Otol       Date:  1989-07

7.  MRI screening of the cerebellopontine angle and inner ear with fast spin-echo T2 technique.

Authors:  B Kovacsovics; L Davidsson; H Harder; B Magnuson; T Ledin
Journal:  Arch Ital Biol       Date:  2000-01       Impact factor: 1.000

8.  Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

9.  Hearing preservation in neurofibromatosis type 2.

Authors:  W H Slattery; D E Brackmann; W Hitselberger
Journal:  Am J Otol       Date:  1998-09

10.  Volume growth rate of acoustic neurinomas.

Authors:  E M Laasonen; H Troupp
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

View more
  13 in total

1.  CT volumetry of intravertebral cement after kyphoplasty. Comparison of polymethylmethacrylate and calcium phosphate in a 12-month follow-up.

Authors:  M Libicher; M Vetter; I Wolf; G Noeldge; C Kasperk; I Grafe; K Da Fonseca; J Hillmeier; P J Meeder; H P Meinzer; G W Kauffmann
Journal:  Eur Radiol       Date:  2005-04-05       Impact factor: 5.315

2.  Expectant management of vestibular schwannoma: a retrospective multivariate analysis of tumor growth and outcome.

Authors:  Mark Hughes; Christopher Skilbeck; Shakeel Saeed; Robert Bradford
Journal:  Skull Base       Date:  2011-09

Review 3.  Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis.

Authors:  Abdullah Egiz; Hritik Nautiyal; Andrew F Alalade; Nihal Gurusinghe; Gareth Roberts
Journal:  J Neurooncol       Date:  2022-06-27       Impact factor: 4.506

4.  Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol.

Authors:  O W M Meijer; E J Weijmans; D L Knol; B J Slotman; F Barkhof; W P Vandertop; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-22       Impact factor: 3.825

5.  Comparing size evaluation methods for acoustic neuroma after stereotactic radiosurgery.

Authors:  Anneyuko I Saito; Christopher G Morris; Kana Ito; Futoshi Watanabe; Kumiko Karasawa; William M Mendenhall; Yutaka Naoi
Journal:  Radiat Med       Date:  2007-08-27

6.  Comparison of contrast-enhanced T1-weighted and 3D constructive interference in steady state images for predicting outcome after hearing-preservation surgery for vestibular schwannoma.

Authors:  M Kocaoglu; N Bulakbasi; T Ucoz; B Ustunsoz; Y Pabuscu; C Tayfun; I Somuncu
Journal:  Neuroradiology       Date:  2003-06-11       Impact factor: 2.804

7.  Vestibular schwannomas: Accuracy of tumor volume estimated by ice cream cone formula using thin-sliced MR images.

Authors:  Hsing-Hao Ho; Ya-Hui Li; Jih-Chin Lee; Chih-Wei Wang; Yi-Lin Yu; Dueng-Yuan Hueng; Hsin-I Ma; Hsian-He Hsu; Chun-Jung Juan
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

8.  Follow-up assessment of vestibular schwannomas: volume quantification versus two-dimensional measurements.

Authors:  Rick van de Langenberg; Bert Jan de Bondt; Patty J Nelemans; Brigitta G Baumert; Robert J Stokroos
Journal:  Neuroradiology       Date:  2009-05-06       Impact factor: 2.804

9.  Semi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis.

Authors:  Alan Jackson; Ka-Loh Li; Xiaoping Zhu
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

10.  A comparison of semi-automated volumetric vs linear measurement of small vestibular schwannomas.

Authors:  Samuel MacKeith; Tilak Das; Martin Graves; Andrew Patterson; Neil Donnelly; Richard Mannion; Patrick Axon; James Tysome
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-01-15       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.